Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Amount Raised
$32.5 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Oak Hill Bio has successfully secured $32.5 million in a Series A funding round. This investment will help the company advance its innovative projects in the pharmaceutical sector. The funding will enhance their research and development capabilities. The round marks a significant milestone for Oak Hill Bio.
Related People
Suggested for you
1 contactVerified contactsNo contacts on file at Oak Hill Bio yet.
Funding Insights
Based on industry dataTypical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech